title: Predicting the Benefit of Statins in Patients With Diabetes Mellitus: A Case of Perfect Being the Enemy of Good?
authors.affiliation: From the Department of Medicine, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City. suz.v.arnold@gmail.com.
authors.forename: Suzanne V
authors.initials: SV
authors.lastname: Arnold
authors.affiliation: From the Department of Medicine, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City.
authors.forename: Mikhail
authors.initials: M
authors.lastname: Kosiborod
mesh_terms: D003920:Diabetes Mellitus; D003924:Diabetes Mellitus, Type 2; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors
keywords: Editorials; decision making; diabetes mellitus; population groups; risk assessment